Jpn. J. Infect. Dis., 65 (5), 448-450, 2012
To see a printable version of the article in the Adobe file format, click this [PDF] link.
Eiji Konishi1,2,3*, Yoko Kitai1, Koichi Nishimura4, and Seiya Harada4
1Division of Infectious Diseases, Department of International Health, Kobe University Graduate School of Health Sciences, Kobe 654-0142; 2Division of Vaccinology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe 650-0017; 4Division of Microbiology, Kumamoto Prefectural Institute of Public Health and Environmental Science, Kumamoto 869-0425, Japan; and 3BIKEN Endowed Department of Dengue Vaccine Development, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Communicated by Masayuki Saijo
(Accepted June 14, 2012)
*Corresponding author: Mailing address: BIKEN Endowed Department of Dengue Vaccine Development, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. Tel: +66-2-354-5981, E-mail: このメールアドレスはスパムボットから保護されています。閲覧するにはJavaScriptを有効にする必要があります。